Navigation Links
Oil spill threatens toothy marine predator that is cultural and historic icon
Date:5/27/2010

nditions would become favorable for both sawfish species eventually to stage a comeback in Gulf waters, Burgess said. Far more common to South and Central America, the largetooth sawfish migrated up the Central American coast during the summer into the Gulf, the edge of its natural geographic range, he said.

"If important underwater habitat is destroyed, neither species will have a place to return to," he said. "They can't come back to an underwater desert."

A creature of historic and cultural interest, the sawfish was sometimes depicted as a so-called monster on postcards from the turn of the century, with stories of its catching routinely published in newspapers outside Florida, Burgess said. Today it is not unusual to find the fish's "saw" hanging from the walls of South Florida bars, he said.

The last time a largetooth sawfish was seen in United States waters was in 1961, said Burgess, who is curator of the National Sawfish Encounter Database, a compendium of all known historic and current records of sawfish in the United States. The predator's close relative, the smalltooth sawfish, once swam in bays, lagoons and rivers extending from New York to the Rio Grande, he said.

The sawfish's fearsome, long, toothy snout is utilized to stun fishes and unearth crustaceans, shellfish and other food buried in the bottom.

The National Marine Fisheries Service's proposed listing of the largetooth sawfish as an endangered species came after UF researchers provided detailed information about its distribution range and trends in abundance to federal officials in response to a petition asking that the fish receive the designation.

In 2008, five years after the smalltooth sawfish was listed as endangered, UF became keeper of the National Sawfish Encounter Database. Besides serving as its overseer, Burgess also is curator of the International Shark Attack File. Both national records collections are housed at the Florida Muse
'/>"/>

Contact: George Burgess
gburgess@flmnh.ufl.edu
352-392-2360
University of Florida
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Scientists to study impact of gulf oil spill on marine food webs
2. Clean-up tools may help protect wetlands from Gulf of Mexico oil spill
3. NASA deploys planes, targets satellites to aid in oil spill response
4. Envisat monitors oil spill proximity to Loop Current
5. Caution required for Gulf oil spill clean-up
6. Spill Central at University of Miami
7. Oil spill in the Gulf of Mexico nears the coast
8. Microbes in mud flats clean up oil spill chemicals
9. The Prestige oil spill caused changes in the cell structure of mussels
10. Arctic governments and industry still unprepared for oil spills 20 years after Exxon Valdez
11. Cleaning up oil spills can kill more fish than spills themselves, say Queens biologists
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2015)... Conn. , Feb. 23, 2015 NXT-ID, ... or the "Company"), a biometric authentication company focused on ... has filed provisional patent 62114357 for DISTRIBUTED ... this patent, NXT-ID introduces a new groundbreaking payment method. ... the payment account may only be accessed if both ...
(Date:2/12/2015)... 12, 2015   MedNet Solutions , a ... study management systems, has recently bolstered its ... iMedNet as the eClinical ... and healthcare consultants.  Building on the Program,s existing ... and numerous co-marketing opportunities), MedNet,s new and improved ...
(Date:2/9/2015)... Feb. 9, 2015  Lintec of America recently announced ... carbon nanotube (CNT) macrostructures, including sheets, yarns and ribbons, ... Leveraging the vast industrial resources of the ... , Lintec of America is forming the Nano-Science ... , focusing on scaling up the manufacturing and ...
Breaking Biology News(10 mins):NXT-ID Patents Voice Directed Payments 2NXT-ID Patents Voice Directed Payments 3MedNet Solutions Announces Key Enhancements To Its iMedNet Partner Program 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4
... technologies from more than 850 scientific, technical and educational ... Annual Meeting, Frontiers in Optics (FiO) 2011, being held Oct. ... Claire hotels in San Jose, Calif. Held in conjunction with ... Society (APS) Division of Laser Science (DLS), the meeting will ...
... The U.S. Department of Energy (DOE) awarded $5.5 ... develop the oilseed plant camelina ( Camelina sativa ) ... totaling $156 million, were awarded by the Advanced Research ... cutting-edge energy technology projects aimed at dramatically improving how ...
... 2011 A young scientist who led research into the use ... disease has been named the winner of the Young Investigator Award ... be presented with her award at The Stem Cell Symposium, hosted ... The $10,000 prize is awarded annually to a young scientist whose ...
Cached Biology News:Optics innovations to be showcased during OSA's Annual Meeting, Frontiers in Optics 2011 2Optics innovations to be showcased during OSA's Annual Meeting, Frontiers in Optics 2011 3Optics innovations to be showcased during OSA's Annual Meeting, Frontiers in Optics 2011 4Danforth Plant Science Center awarded major bioenergy grant from US Department of Energy 2Danforth Plant Science Center awarded major bioenergy grant from US Department of Energy 3Regenerating eyes using cells from hair: Stem Cells awards research into stem cell deficiency 2
(Date:3/4/2015)... , March 4, 2015  BioClinica®, Inc., ... technology provider, today announced that clinical trial ... convened at its annual European User Conference ... to discuss the use of its eClinical ... eClinical technologies include: the Microsoft Office-Smart OnPoint ...
(Date:3/4/2015)... California (PRWEB) March 04, 2015 ... (PCR) represents one of the fastest growing technologies in ... biologists in subcellular visualization is driving growth in nucleic ... for deeper understanding of gene expressions will continue to ... Expanding applications in fields ranging from pharma, biotech, food ...
(Date:3/4/2015)... 4, 2015 Lancée ... Paris en décembre 2011, l,étude collaborative ... », qui compare   l es microsphères ... sorafénib dans le carcinome hépatocellulaire avancé, a recruté ... foie avancé   ; les résultats sont attendus ...
(Date:3/3/2015)... March 3, 2015 /PRNewswire/ - Aptose Biosciences Inc. (NASDAQ: ... and molecular diagnostics that target the underlying mechanisms of ... seventh-month period ended December 31, 2014. Effective ... end from May 31 to December 31. As a ... today are for the quarter and the seven months ...
Breaking Biology Technology:BioClinica Teams With Pharma To Tackle Clinical Trial Challenges In Europe 2BioClinica Teams With Pharma To Tackle Clinical Trial Challenges In Europe 3Focus on Quantifying Nucleic Acid Molecules Spurs Growth in the qPCR & dPCR Instrumentation Market, According to a New Report by Global Industry Analysts, Inc. 2Focus on Quantifying Nucleic Acid Molecules Spurs Growth in the qPCR & dPCR Instrumentation Market, According to a New Report by Global Industry Analysts, Inc. 3Focus on Quantifying Nucleic Acid Molecules Spurs Growth in the qPCR & dPCR Instrumentation Market, According to a New Report by Global Industry Analysts, Inc. 4Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 2Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 3Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 4Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 5Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 6Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 2Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 3Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 4Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 5Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 6Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 7Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 8Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 9Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 10Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 11Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 12
... Placement -, - $10 Million Principal Amount of Debt Exchanged for ... ... Stock -, DALLAS, Nov. 8 Access Pharmaceuticals, Inc.,(OTC Bulletin ... million recapitalization. The Company has entered,into agreements with institutional investors to ...
... Clinical ... ... Genta,Incorporated (Nasdaq: GNTA ) today announced the presentation of ... in combination with Abraxane(R) (paclitaxel protein-bound,particles for injectable suspension) (albumin-bound; ...
... p.m. (Pacific); ... , SAN DIEGO, Nov. 7 ADVENTRX Pharmaceuticals,Inc. ... company,focused on commercializing proprietary product candidates for the treatment,of ... three-month and nine-month periods ended September 30, 2007. ...
Cached Biology Technology:Access Pharmaceuticals Announces $19.5 Million Recapitalization 2Access Pharmaceuticals Announces $19.5 Million Recapitalization 3Genasense(R) Triple Combination Therapy in Advanced Melanoma Presented at Chemotherapy Foundation Symposium 2Genasense(R) Triple Combination Therapy in Advanced Melanoma Presented at Chemotherapy Foundation Symposium 3Genasense(R) Triple Combination Therapy in Advanced Melanoma Presented at Chemotherapy Foundation Symposium 4ADVENTRX Pharmaceuticals Reports Third Quarter 2007 Financial Results 2ADVENTRX Pharmaceuticals Reports Third Quarter 2007 Financial Results 3ADVENTRX Pharmaceuticals Reports Third Quarter 2007 Financial Results 4ADVENTRX Pharmaceuticals Reports Third Quarter 2007 Financial Results 5ADVENTRX Pharmaceuticals Reports Third Quarter 2007 Financial Results 6ADVENTRX Pharmaceuticals Reports Third Quarter 2007 Financial Results 7
Concentration: 1mg/ml. Antigen: Propidium Iodide ...
... plastic feeding tubes for rodent oral gavage ... risk of perforation and trauma. Plus they ... cleaning and the risk of cross-contamination. ... 20ga Length: ...
Adult Bovine Serum US Origin...
... the 9, 10, 12, and 13 positions. It ... for the quantification of 13(S)-HODE by GC- or ... linoleic acid with plant and mammalian lipoxygenases. It ... tumor cells to the endothelium at concentrations around ...
Biology Products: